Skip to main content
Clinical Trials/NL-OMON32858
NL-OMON32858
Completed
Not Applicable

A multicenter randomized clinical trial investigating the cost-effectiveness of treatment strategies with or without antibiotics for uncomplicated acute diverticulitis - DIABOLO trial

Academisch Medisch Centrum0 sites533 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Complicated diverticular disease
Sponsor
Academisch Medisch Centrum
Enrollment
533
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Only left\-sided uncomplicated (mild) acute diverticulitis;
  • 2\. Clinical suspicion of acute diverticulitis. For acute diagnostic work\-up: ultrasound or CT proven diverticulitis. In the case of diverticulitis\-negative ultrasound in clinically suspected patients an intravenous contrast\-enhanced CT scan is mandatory for confirmation of diverticulitis or exclusion of other pathology. CT for Hinchey/Ambrosetti classification (which is a CT\-based classification system) is needed for all patients, but can be delayed 1 day in those with ultrasound diagnosis. Staging diverticultis is defined according the modified Hinchey/Ambrosetti staging, only stages 1a and 1b and mild diverticulitis are included;
  • 3\. All patients with informed consent.

Exclusion Criteria

  • 1\. Previous radiological (ultrasound and/or CT) proven episode of diverticulitis;
  • 2\. Colonic cancer;
  • 3\. Inflammatory bowel disease (ulcerative colitis, Crohn's disease);
  • 4\. Hinchey stages 2, 3 and 4 or severe diverticulitis according to the Ambrosetti criteria, which require surgical or percutaneous treatment;
  • 5\. Disease with expected survival of less than 6 months;
  • 6\. Contraindication for the use of the study medication (e.g. patients with advanced renal failure or allergy to antibiotics used in this study);
  • 7\. Pregnancy, breastfeeding;
  • 8\. ASA (American Society of Anaesthesiologists) classification \> III;
  • 9\. Immunocompromised patients;
  • 10\. Clinical suspicion of bacteraemia (i.e. sepsis);

Outcomes

Primary Outcomes

Not specified

Similar Trials